ProQR Therapeutics NV (PRQR)
1.435
+0.02
(+1.77%)
USD |
NASDAQ |
Jun 11, 16:00
1.435
0.00 (0.00%)
After-Hours: 18:27
ProQR Therapeutics Total Liabilities (Quarterly) : 70.79M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 70.79M |
| December 31, 2025 | 74.44M |
| September 30, 2025 | 79.05M |
| June 30, 2025 | 82.82M |
| March 31, 2025 | 78.59M |
| December 31, 2024 | 82.22M |
| September 30, 2024 | 91.37M |
| June 30, 2024 | 91.31M |
| March 31, 2024 | 96.18M |
| December 31, 2023 | 106.59M |
| September 30, 2023 | 101.32M |
| June 30, 2023 | 105.27M |
| March 31, 2023 | 107.90M |
| December 31, 2022 | 111.68M |
| September 30, 2022 | 56.03M |
| June 30, 2022 | 96.26M |
| March 31, 2022 | 100.16M |
| December 31, 2021 | 109.57M |
| September 30, 2021 | 78.01M |
| June 30, 2021 | 53.14M |
| March 31, 2021 | 49.87M |
| December 31, 2020 | 51.61M |
| September 30, 2020 | 49.37M |
| June 30, 2020 | 15.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.45M |
| December 31, 2019 | 26.61M |
| September 30, 2019 | 23.60M |
| June 30, 2019 | 22.80M |
| March 31, 2019 | 23.37M |
| December 31, 2018 | 20.06M |
| September 30, 2018 | 19.27M |
| June 30, 2018 | 17.29M |
| March 31, 2018 | 15.76M |
| December 31, 2017 | 16.54M |
| September 30, 2017 | 15.20M |
| June 30, 2017 | 13.23M |
| March 31, 2017 | 13.25M |
| December 31, 2016 | 13.09M |
| September 30, 2016 | 12.80M |
| June 30, 2016 | 14.44M |
| March 31, 2016 | 12.76M |
| December 31, 2015 | 11.20M |
| September 30, 2015 | 10.21M |
| June 30, 2015 | 10.47M |
| March 31, 2015 | 8.222M |
| December 31, 2014 | |
| September 30, 2014 | 6.854M |
| June 30, 2014 | 6.954M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pharming Group NV | 220.41M |
| NewAmsterdam Pharma Co. NV | 67.42M |
| Kamada Ltd. | 123.63M |
| Syndax Pharmaceuticals, Inc. | 431.05M |
| Opus Genetics, Inc. | 112.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.11M |
| Shareholders Equity (Quarterly) | 43.32M |
| Debt to Equity Ratio | 0.364 |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | 0.04% |